Patent details

EP2594272 Title: Aerosolized fluoroquinolones and uses thereof

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2594272
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12007354.9
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
18/05/2006
Grant date:
11/07/2018
EP Publication Date:
22/05/2013
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
16/08/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
11/07/2018
EP B1 Publication Date:
11/07/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/05/2026
Lapsed By Expiration Date:
Patent Validated Date:
28/08/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
02/01/2024
 
 

 

Name:
Horizon Therapeutics U.S. Holding LLC
Address:
1 Horizon Way, 60015, Deerfield, Illinois, United States of America (US)

Historical Applicant/holder

From:
11/07/2018
To:
02/01/2024

 

Name:
Horizon Orphan LLC
Address:
150 South Saunders Road, Lake Forest, IL 60045, United States of America (US)

Agent

Name:
J.M.H. Duyver lic.
From:
27/08/2018
Address:
Gevers Patents De Kleetlaan 7A, B-1831, Diegem, Belgium (BE)
To:

Inventor

1

Name:
Bostian, Keith A.
Address:
Seattle, WA 98104, United States of America (US)

2

Name:
Dudley, Michael N.
Address:
San Diego, CA 92127, United States of America (US)

3

Name:
Surber, Mark
Address:
Coronado, CA 92118, United States of America (US)

4

Name:
Griffith, David C.
Address:
San Marcos, CA 92127, United States of America (US)

5

Name:
Lomovskaya, Olga
Address:
Mill Valley, CA 94941, United States of America (US)

Priority

1

Priority Patent Number:
773300 P
Priority Date:
13/02/2006
Priority Country:
United States of America (US)

2

Priority Patent Number:
696160 P
Priority Date:
01/07/2005
Priority Country:
United States of America (US)

3

Priority Patent Number:
682530 P
Priority Date:
18/05/2005
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 9/08; A61K 9/12; A61K 31/4375; A61K 31/47; A61K 31/538; A61K 31/5383; A61K 33/06; A61K 33/14; A61P 11/00;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
02/24
Publication date:
10/01/2024
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
36/18
Publication date:
29/08/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
29/18
Publication date:
11/07/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201828
Publication date:
11/07/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC202400013A
Date Registered:
02/01/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Horizon Therapeutics U.S. Holding LLC
Address:
1 Horizon Way, 60015, Deerfield, Illinois, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/05/2025
Annual Fee Number:
20
Annual Fee Amount:
1400 Euro
Last Annual Payment Date:
20/05/2024
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
1300 Euro
Payer:
Maxval Group
Filing date Document type Document Description Number of pages File Type
27/08/2018 Outgoing Correspondence Letter no formal defects 1 PDF /5/9/7/8/8/0800288795/docs/ep12007354.9_0_225028l271.pdf
16/08/2018 Claims First filed claims 4 PDF /5/9/7/8/8/0800288795/docs/ep12007354.9_1_claims20180816134211010.pdf
16/08/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /5/9/7/8/8/0800288795/docs/ep12007354.9_2_incomingcorrespondenceelectronic20180816134211670.pdf